Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Extraskeletal myxoid chondrosarcoma is an aggressive tumor in children. Due to its low incidence and nonspecific clinical presentation, as well as its radiological and histopathological characteristics, it is considered a diagnostic challenge. Furthermore, despite the NR4A3 rearrangement being specific to this neoplasm, its evaluation is not routinely performed, as few places have the technology to characterize it. We present the case of a 12-year-old girl with extraskeletal myxoid chondrosarcoma in the right thigh associated with lung metastasis. The diagnosis was ultimately made by integrating the clinical, radiological, histopathological, and ultrastructural features of the chondroblastic differentiation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12285907 | PMC |
| http://dx.doi.org/10.7759/cureus.86605 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The role of radiotherapy and chemotherapy in extraskeletal myxoid chondrosarcoma.
J Orthop Surg Res
August 2025
Division of Musculoskeletal Oncology, National Cancer Center Hospital, 5-1- 1 Tsukiji, Chuoku, Tokyo, 104-0045, Japan.
Background: Extraskeletal myxoid chondrosarcoma (EMC) is an extremely rare subtype of sarcoma characterized by NR4A3 gene rearrangement. Despite being considered slowly progressive sarcomas, EMCs tend to have local recurrences and distant metastases in the late stages. This study aimed to investigate the prognostic factors of EMCs, especially the effect of (neo)adjuvant radiotherapy or chemotherapy on localized EMCs and chemotherapy on advanced-stage EMCs.
View Article and Find Full Text PDFDiagnosis and Management of Large Extraosseous Myxoid Chondrosarcoma of the Buttocks: A Case Report.
Am J Case Rep
August 2025
Department of Burn Plastic Surgery and Wound Repair, Ganzhou People's Hospital, Ganzhou, Jiangxi, China.
BACKGROUND Extraskeletal chondrosarcoma is a rare soft tissue sarcoma with no characteristic imaging and clinical manifestations. Therefore, early preoperative diagnosis is difficult and ultimately depends on postoperative pathology and genetic diagnosis. CASE REPORT A 67-year-old man presented with a huge buttock tumor.
View Article and Find Full Text PDFSecondary Genetic Alterations in Extraskeletal Myxoid Chondrosarcoma.
Genes Chromosomes Cancer
August 2025
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Extraskeletal myxoid chondrosarcoma (EMC) is a rare mesenchymal neoplasm of uncertain histogenesis, characterized by recurrent gene fusions involving NR4A3 with various gene partners (EWSR1, TAF15, FUS, etc.). Although the impact of fusion variants has been linked to histology and prognosis, no study to date has comprehensively investigated the incidence and spectrum of secondary genetic alterations (SGAs) in EMC with regard to their association with fusion type and clinical impact.
View Article and Find Full Text PDFExtraskeletal Myxoid Chondrosarcoma With Rhabdoid Features in a Pediatric Patient.
Cureus
June 2025
Pathology, Instituto Nacional de Pediatría, Mexico City, MEX.
Extraskeletal myxoid chondrosarcoma is an aggressive tumor in children. Due to its low incidence and nonspecific clinical presentation, as well as its radiological and histopathological characteristics, it is considered a diagnostic challenge. Furthermore, despite the NR4A3 rearrangement being specific to this neoplasm, its evaluation is not routinely performed, as few places have the technology to characterize it.
View Article and Find Full Text PDFCT and MRI findings of intracranial extraskeletal mesenchymal and myxoid chondrosarcoma: report of 3 rare cases and literature review.
Neurol Sci
July 2025
Department of Radiology, The Affiliated Huaian Hospital of Xuzhou Medical University, Huaian, 223001, Jiangsu, China.